企業プロフィール
Dr. Reddy's Laboratories Ltd 株価・ニュース・カタリスト
- ティッカー:
- RDY
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- India and listed in the U
株価パフォーマンス
12.25 USD (-2.93%)
終値
最終更新: 2026年10月1日
10.8B USD
時価総額
株価変動の要因
2026年10月1日 時点で RDY は 2.93% 下落し、$12.25 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
India-Based Global Pharmaceutical Company
Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in India. Its businesses include generic medicines, branded formulations, biosimilars, active pharmaceutical ingredients, pharmaceutical services, consumer health products, and selected innovative drug-development programs.
Global Generics Business
The Global Generics segment operates across North America, Europe, India, and emerging markets. It supplies oral solids, injectables, dermatology products, complex generics, and branded generics, with local commercial organizations adapting the portfolio to each market's regulatory and prescribing structure.
Branded and Consumer Health Portfolio
India and emerging markets contain substantial branded-prescription businesses, while acquired nicotine-replacement products have expanded the company's consumer-health presence. These businesses provide a different commercial model from the more price-sensitive U.S. generics market.
Pharmaceutical Services and APIs
The Pharmaceutical Services and Active Ingredients segment develops and manufactures active pharmaceutical ingredients and provides related capabilities to external customers. Vertical integration also supports selected finished-dose products and gives Dr. Reddy's experience in complex chemistry and global quality systems.
Peptides, Biosimilars, and Innovative Assets
The growth pipeline emphasizes peptides, biosimilars, and differentiated products. Programs involving semaglutide, abatacept, and other complex molecules are intended to move the company beyond conventional small-molecule generics while leveraging its development and manufacturing scale.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。